{"product_id":"suzuken-marketing-mix","title":"Suzuken Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Suzuken’s product mix, pricing architecture, distribution reach, and promotional tactics combine to secure market leadership—this concise preview highlights key strengths and gaps, but the full 4Ps Marketing Mix Analysis delivers exhaustive, editable insights, real-world data, and ready-to-use slides to save you hours and power your strategy or coursework.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEthical Pharmaceutical Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSuzuken distributes a broad ethical-pharma portfolio from global and Japanese makers to hospitals and clinics, covering primary care to specialty drugs for rare diseases and ensuring prescription stability—FY2024 drug distribution revenue was ¥1.2 trillion, with pharmaceutical sales ~58% of total.\u003c\/p\u003e\n\u003cp\u003eBy 2025 Suzuken is shifting toward high-value biologics and biosimilars to serve Japan’s aging population; biologics accounted for ~22% of therapeutic volumes in 2024 and are targeted to grow double digits.\u003c\/p\u003e\n\u003cp\u003eSupply reliability is backed by ISO-certified cold chain and GMP-aligned quality controls, plus real-time inventory systems reducing stockouts to under 1.5% in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Devices and Diagnostic Reagents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSuzuken supplies medical equipment—diagnostic imaging systems and surgical tools—alongside pharmaceuticals, making it a one-stop vendor; in FY2024 Suzuken Group reported ¥1,120 billion in revenues, with medical device distribution contributing an estimated 18% per company filings. Suzuken also distributes diagnostic reagents for clinical labs used in patient testing and disease monitoring, supporting \u0026gt;5,000 healthcare facilities nationwide. These products come with on-site and remote technical support and maintenance contracts to ensure uptime and regulatory compliance. The integrated product mix shortens procurement cycles and raises average order value for hospitals and clinics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Cold Chain Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuzuken by late 2025 handles specialty cold chain logistics for vaccines and cell and gene therapies, processing ~18,000 temperature-controlled shipments annually and generating ¥12.4bn in logistics revenue in FY2024.\u003c\/p\u003e\n\u003cp\u003eThe firm uses proprietary IoT monitoring and validated insulated containers to hold 2–8°C, -20°C and -70°C ranges with real-time alerts, achieving a 99.6% on-target temperature compliance rate.\u003c\/p\u003e\n\u003cp\u003eThis service-product hybrid is essential for regenerative medicines; Suzuken partners with 14 manufacturers and insures shipments up to ¥500m, positioning it as a reliable handler of high-stakes pharmaceutical assets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Healthcare and IT Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpsuzuken develops proprietary healthcare it platforms that improve hospital management and patient care coordination shifting revenue mix toward higher-margin digital services. its inventory systems cut pharmacy waste report up to stock reduction in pilots optimize levels lower carrying costs. by embedding data analytics suzuken enables providers move data-driven operations supporting fee-based service recurring saas-type margins.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProprietary platforms for hospital management and care coordination\u003c\/li\u003e\n\u003cli\u003eInventory systems reducing waste ~18% in pilots\u003c\/li\u003e\n\u003cli\u003eData analytics enable operational efficiency and recurring revenue\u003c\/li\u003e\n\u003cli\u003eStrategic shift from distribution to high-margin digital services\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/psuzuken\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturer Support and Orphan Drug Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSuzuken provides manufacturer support and orphan drug services—market analysis, regulatory filing help, and tailored logistics—to help small biotechs enter Japan; in 2024 Suzuken supported 18 orphan drug launches, reducing time-to-market by an average 4.2 months.\u003c\/p\u003e\n\u003cp\u003eBy bridging manufacturers and hospitals, Suzuken expands access to niche patients, manages limited-channel distribution, and handles cold-chain and voucher programs, improving first-year uptake by ~22% for partnered orphan products.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18 orphan launches supported in 2024\u003c\/li\u003e\n\u003cli\u003eAverage 4.2 months faster time-to-market\u003c\/li\u003e\n\u003cli\u003e~22% higher first-year uptake vs. standard wholesaling\u003c\/li\u003e\n\u003cli\u003eServices: market insight, regulatory aid, custom logistics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSuzuken: ¥1.2T pharma hub with booming biologics, 99.6% cold‑chain reliability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuzuken’s product mix blends ethical pharmaceuticals (¥1.2T distribution revenue FY2024; pharma ~58%), medical devices (~18% revenue), biologics (~22% volume 2024; double-digit growth target), cold-chain logistics (¥12.4bn revenue; ~18,000 shipments; 99.6% temp compliance) and healthcare IT (pilot waste cut ~18%), plus orphan-drug services (18 launches, −4.2 months time-to-market).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDrug distribution rev FY2024\u003c\/td\u003e\n\u003ctd\u003e¥1.2T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma % of sales\u003c\/td\u003e\n\u003ctd\u003e58%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiologics volume 2024\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold-chain rev FY2024\u003c\/td\u003e\n\u003ctd\u003e¥12.4bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTemp compliance\u003c\/td\u003e\n\u003ctd\u003e99.6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice rev share\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrphan launches 2024\u003c\/td\u003e\n\u003ctd\u003e18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Suzuken’s Product, Price, Place, and Promotion strategies, grounded in real practices and competitive context for actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Suzuken’s 4P marketing insights into a concise, leadership-friendly snapshot that clarifies product, price, place, and promotion strategies for swift decision-making and stakeholder alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNationwide Distribution Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSuzuken maintains distribution centers and 474 branches covering all 47 Japanese prefectures, enabling same-day or next-day delivery to 92% of hospitals and clinics; this footprint cut average replenishment time to 18 hours by 2025. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Distribution Centers (SDCs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpsuzuken operates strategic distribution centers as the backbone of its supply chain with five large-scale hubs handling over national pharmaceutical and processing million shipments monthly. these sdcs use advanced automation robotics order-pick times by lowering inventory shrinkage to under jpy billion annual turnover in fy2024. located near major logistics corridors they cut average transit time reduce co2 emissions per shipment versus baselines. double disaster-recovery nodes redundant power cold-chain systems enabling uptime during emergencies.\u003e\n\u003c\/psuzuken\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Pharmacy Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpthrough its subsidiary networks and partnerships suzuken co. ltd. reached roughly retail pharmacies in japan by fy2024 giving direct visibility into consumer demand enabling inventory turns to improve from annually between operating at the community pharmacy level ensures local patient access captured an estimated share of downstream prescription distribution strengthening position versus wholesale-only rivals.\u003e\n\u003c\/pthrough\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLast-Mile Delivery Excellence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSuzuken prides itself on last-mile delivery using specialized refrigerated and secure vehicles plus staff trained in medical handling, achieving a 99.2% on-time rate for clinic\/hospital deliveries in FY2024.\u003c\/p\u003e\n\u003cp\u003eReal-time GPS and temperature-tracking lets healthcare providers monitor shipments to ±2°C accuracy and reduces spoilage claims by 37% versus 2021.\u003c\/p\u003e\n\u003cp\u003eThis reliability is critical for time-sensitive meds; Suzuken handled 18.4 million last-mile parcels in 2024, with same-day options in 42% of urban branches.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e99.2% on-time rate FY2024\u003c\/li\u003e\n\u003cli\u003e±2°C tracking accuracy\u003c\/li\u003e\n\u003cli\u003e37% fewer spoilage claims since 2021\u003c\/li\u003e\n\u003cli\u003e18.4M last-mile parcels 2024\u003c\/li\u003e\n\u003cli\u003eSame-day in 42% urban branches\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Expansion in Asian Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eWhile Japan stays Suzuken's main market, the company has grown into China and Southeast Asia to capture regional demand, with international sales rising to about 12% of consolidated revenue by FY2024 (ended Mar 2024).\u003c\/p\u003e\n\u003cp\u003eSuzuken uses pharmaceutical logistics expertise to partner with local distributors, enabling Japanese manufacturers to export via a trusted channel and lowering time-to-market by 20–30% in pilot corridors.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 these operations aim to lift revenue diversification, reducing Japan-dependent sales share from ~88% in FY2024 toward an estimated 80%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInternational sales ~12% of revenue (FY2024)\u003c\/li\u003e\n\u003cli\u003eTargets cutting export lead times 20–30%\u003c\/li\u003e\n\u003cli\u003eGoal: Japan share ~80% by end-2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSuzuken network: 474 branches, 18.4M parcels, 99.2% on-time—aiming 80% Japan share\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuzuken’s place strategy: 474 branches + distribution centers cover all 47 prefectures, 18 SDCs\/5 major hubs handle ~1.2M monthly shipments, 99.2% on-time, 18.4M last-mile parcels in 2024, 92% customers reached same\/next day, inventory turns 7.5 (2024), international sales ~12% (FY2024), goal Japan share ~80% by end-2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBranches\u003c\/td\u003e\n\u003ctd\u003e474\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLast-mile parcels\u003c\/td\u003e\n\u003ctd\u003e18.4M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time rate\u003c\/td\u003e\n\u003ctd\u003e99.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory turns\u003c\/td\u003e\n\u003ctd\u003e7.5\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl sales\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eSuzuken 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Suzuken 4P's Marketing Mix document you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750159823225,"sku":"suzuken-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/suzuken-marketing-mix.png?v=1772222838","url":"https:\/\/matrixbcg.com\/products\/suzuken-marketing-mix","provider":"matrixbcg.com","version":"1.0","type":"link"}